Cargando…
Development and Validation of a High-Performance Liquid Chromatography with Tandem Mass Spectrometry (HPLC-MS/MS) Method for Quantification of Major Molnupiravir Metabolite (β-D-N4-hydroxycytidine) in Human Plasma
Molnupiravir is an antiviral drug against viral RNA polymerase activity approved by the FDA for the treatment of COVID-19, which is metabolized to β-D-N4-hydroxycytidine (NHC) in human blood plasma. A novel method was developed and validated for quantifying NHC in human plasma within the analytical...
Autores principales: | Komarov, Timofey, Karnakova, Polina, Archakova, Olga, Shchelgacheva, Dana, Bagaeva, Natalia, Popova, Mariia, Karpova, Polina, Zaslavskaya, Kira, Bely, Petr, Shohin, Igor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525314/ https://www.ncbi.nlm.nih.gov/pubmed/37760797 http://dx.doi.org/10.3390/biomedicines11092356 |
Ejemplares similares
-
The development and validation of a novel LC-MS/MS method for the simultaneous quantification of Molnupiravir and its metabolite ß-d-N4-hydroxycytidine in human plasma and saliva
por: Amara, Alieu, et al.
Publicado: (2021) -
Could chlorophyllins improve the safety profile of beta-d-N4-hydroxycytidine
versus N-hydroxycytidine, the active ingredient of the SARS-CoV-2 antiviral
molnupiravir?
por: Clark, Nicole F., et al.
Publicado: (2022) -
Inhibitors of dihydroorotate dehydrogenase cooperate with molnupiravir and N4-hydroxycytidine to suppress SARS-CoV-2 replication
por: Stegmann, Kim M., et al.
Publicado: (2022) -
Oxidative DNA Damage by N(4)-hydroxycytidine, a Metabolite of the SARS-CoV-2 Antiviral Molnupiravir
por: Kobayashi, Hatasu, et al.
Publicado: (2022) -
Transporter modulation of molnupiravir and its metabolite β-D-N4-hydroxycytidine across the blood-brain barrier in a rat
por: Chang, Chun-Hao, et al.
Publicado: (2023)